TRAVERSE; John Fitzgerald

Patent Applications and Registrations

Patent applications and USPTO patent grants for TRAVERSE; John Fitzgerald.The latest application filed is for "preparation of maytansinol".

Company Profile

1.6.7

TRAVERSE; John Fitzgerald - Lebonon NJ
TRAVERSE; John Fitzgerald - Summit NJ
Traverse; John Fitzgerald - Lebanon NJ
Traverse; John Fitzgerald - Roselle Park NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Preparation Of Maytansinol App 20220162230 - TRAVERSE; John Fitzgerald ; et al.	2022-05-26
Process For The Preparation Of Bromodomain Inhibitor App 20220064121 - TRAVERSE; John Fitzgerald ; et al.	2022-03-03
Thiazolidinone and oxazolidinone compounds and formulations Grant 11,014,940 - Traverse , et al. May 25, 2	2021-05-25
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use Grant 9,974,786 - Beauchamps , et al. May 22, 2	2018-05-22
Process for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,- 6-dione and pharmaceutically acceptable salts thereof Grant 9,969,712 - Traverse May 15, 2	2018-05-15
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20180071287 - BEAUCHAMPS; Marie Georges ; et al.	2018-03-15
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,795,603 - Beauchamps , et al. October 24, 2	2017-10-24
Processes For The Preparation Of Isotopologues Of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,- 6-dione And Pharmaceutically Acceptable Salts Thereof App 20170267658 - TRAVERSE; John Fitzgerald	2017-09-21
Processes for the preparation of isotopologues of 3-(4-((4- morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof Grant 9,695,145 - Traverse July 4, 2	2017-07-04
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20170182042 - BEAUCHAMPS; Marie Georges ; et al.	2017-06-29
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,604,939 - Beauchamps , et al. March 28, 2	2017-03-28
Processes For The Preparation Of Isotopologues Of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,- 6-dione And Pharmaceutically Acceptable Salts Thereof App 20150361066 - TRAVERSE; John Fitzgerald	2015-12-17
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20140356430 - BEAUCHAMPS; Marie Georges ; et al.	2014-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.